The in vitro primary response of mouse spleen cell suspensions to 2,4,6-trinitrophenyl(Tnp)-erythrocytes has been studied. The number of anti-Tnp
Observations made with several different experimental models support the hypothesis that two or more cells are required for the immune response. Thus, (a) synergistic effects have been observed between bone marrow and thymus cells when injected into irradiated recipients (1, 2), and the depressed response of neonatally thymectomized mice is restored by injection of thymus or thoracic duct cells (3). Similar effects were observed in vitro (4, 5) . (b) Synergistic effects were also seen when certain cells, separated on the basis of physical properties, such as differential attachment to surfaces (6) (7) (8) (9) (10) (11) or differential sedimentation in density gradients (12-16), were incubated together in vitro. The nature of the helper function of the attached cells in these studies is not yet fully understood, but it would appear to represent the activity of a third cell in addition to the antigen-specific bone marrow and thymus-derived cells described above. (c) Prior injection of the carrier antigen enhances the subsequent response to a hapten coupled to the same carrier (17, 18) , and synergistic effects are seen in the response to a hapten-carrier conjugate of irradiated recipients that have been injected with two populations of cells, one immunized with the carrier and the other with the hapten (19) , or when carrier-primed cells are injected into hapten-primed recipients (20) . Similar synergistic effects were observed by Breitner and Miller (21) and by Trowbridge et al. (22) in in vitro systems.
In many of these experiments, it has been shown that one population supplies the bone-marrow-derived precursor cell while the other population supplies a cell or cells that performs some helper function (2, 5, 11, 14, 19, 23, 24) . Recent experiments have demonstrated some of the interrelationships between these different cooperative effects. Thus, it has been shown that the carrier-primed cells that enhance the hapten response are thym us-derived (25, 26) .
We are concerned here with the characterization of the bone marrow-thymus cell cooperation. We have previously reported a primary immune response against the 2,4,6-trinitrophenyl group (Tnp), a haptenic determinant covalently fixed to an erythrocyte carrier (27) , when mouse spleen cell suspensions were stimulated in vitro (28) .
In this paper we show that the primary in vitro response to a hapten-carrier complex is enhanced by prior immunization with the carrier, and describe experiments in which we have used this system to investigate further the properties of this helper effect of the thymus-derived cell. The principal findings are concerned with the kinetics of the development of "helper"-cell populations and the demonstration that "helper"-cell activity, once developed, is not inhibited by x-irradiation. A preliminary account of some of these experiments has been published (26) , and somewhat similar observations have since been reported by Katz et al. (29) , who studied the enhancement of a secondary response to a hapten, in vivo, in guinea pigs.
MATERIALS AND METHODS Animals
BDF1 (C57BL/6 female X DBA/2 male) mice were used throughout unless otherwise indicated and were bred in our own colony. C57BL/6 and DBA/2 were purchased from Jackson Laboratories, Bar Harbor, Me. Antigens 2,4,6-trinitrophenyl(Tnp)-substituted erythrocytes (RBC) of the sheep, burro, horse, or chicken were prepared as described by Rittenberg and Pratt (30) . Heavily substituted erythrocytes were used as immunogen and lightly substituted erythrocytes as antigen in the assay of antibody-forming cells (plaque-forming cells, PFC) (27) . 1.2 X 107 mouse spleen cells were cultured in 1 ml of a modified Eagle's medium containing 5% fetal bovine serum. The cultures were assayed 2, 3, 4, and 5 days after the addition of antigen. The direct hemolytic plaque assay of Jerne was used to determine the number of antibody-forming cells. The Tnp response of cultures immunized with hapten conjugated to one carrier was assayed using hapten coupled to a second, noncrossreacting carrier (27) . The results are expressed as the number of plaque-form- (27) . The number of PFC is greatly enhanced if the spleen cell donor is immunized with 0.2 ml of a 0.5% v/v suspension of the carrier sheep erythrocytes 3 days before the donor is killed (Table 1) . In other experiments (not documented here) it was shown that this antigen dose was more effective than a higher dose (0.2 ml of 10% v/v sheep RBC suspension). In some cases, priming was achieved with antigen doses as low as 0.2 ml of a 0.005% suspension when no increase of PFC could be observed at the time the mice were killed (Falkoff and Kettman, unpublished observations). The enhancing effect is antigen-specific. Thus, immunization with a noncrossreacting carrier, chicken RBC or burro RBC, was without effect (Expts. 1, 2, 3, 9, and 10; Table 1 ). The simultaneous addition of Tnp-(sheep RBC) plus chicken RBC in chicken RBC-immunized mice gave no enhancement (Expt. 10, Table 1 ). The enhancing effect was also observed with C57BL/6 and DBA/2 mice (Expt. 6, Table 1 ).
In the next experiment, we tested whether the Tnp response of spleen cells from normal mice could be enhanced by the presence of cells from a second group of mice injected 3 days previously with the carrier antigen. The spleen cells from the carrier-primed mice were irradiated with 1000 R, which prevented them from giving rise to any anti-Tnp cells. The results illustrated in Fig. la show that the presence of carrierprimed cells does enhance the anti-Tnp response of spleen cells from normal mice and, furthermore, that this enhancing effect is not abolished by exposure to 1000 R (Fig. lb) The antigen specificity of this enhancing effect is demonstrated in Fig. 2 after antigen injection and can be elicited with very low antigen doses (2 X 104 sheep RBC). It has been suggested that the thymus-derived antigen-reactive cells multiply rapidly after antigenic stimulation (31, 32) , and that irradiation of thymus cell suspensions abolished their ability to restore the responsiveness of neonatally thymectomized mice (33) . It is, therefore, somewhat surprising that the activity of the carrierprimed cell population, once developed, is not abolished by heavy doses of irradiation. A similar apparent insensitivity to radiation of thymus-derived cells was previously observed in the restoration of spleen cell suspensions from neonatally thymectomized mice (4, 5), and Katz et al. (29) (Fig. 3) .
In the next experiment, we examined how soon the enhancing effect of carrier priming develops. Mice were injected with sheep RBC 1, 2, 4, 6, 8, or 14 days before they were killed and the extent of the anti-Tnp response to Tnp-(sheep RBC) was compared with that of spleen cells from normal mice. In two experiments out of three, the response was already increased by day 1 and the effect was marked from days 3 to 14 (Table  3) .
The same effect is shown in experiments where irradiated cells from the mice primed 1, 4, or 14 days before sacrifice were mixed with aliquots from a pool of normal spleen cells. The results of these experiments are illustrated in Fig. 4 .
In other experiments we showed that the enhancing effect of irradiated carrier-primed cells could be abolished by prior treatment with antiserum specific for the thymus antigen 0, plus complement (26) . The same enhancing effect was shown with thymus-derived cells prepared from the spleens of mice irradiated 7 days previously, and injected with thymus cells and antigen (26) . These two pieces of evidence establish the fact that the enhancing effect of carrier-primed spleen cell is mediated by thymus-derived cells. The experiments described are compatible with the hypothesis that a thymus-derived population with specificity for the carrier antigen determinants is required for, or is in some way helpful to, the response to a single identified determinant, such as Tnp. The enhancing activity of carrier-primed cells increases rapidly 
